Danaher stock remains supported by earnings and margins - ad-hoc-news.de
Article excerpt
Highlighted: the sentence this signal was extracted from
Danaher Corp. (ISIN US2358511028) is trading around $196.74, with the stock valued at roughly $141.4 billion as of 20 July 2026. The latest annual report gives investors a clear baseline: 2025 revenue of $23.9 billion, adjusted diluted net earnings per share of $7.66, and an adjusted operating margin of 27.3%. The 2025 revenue figure of $23.9 billion matters because it sits alongside a 5.8% decline in core revenue for the year, according to Danaher's annual report. That combination shows a business that still converted scale into profit, even as underlying demand softened in parts of the portfolio. Adjusted operating profit in 2025 reached 27.3% of sales, which is high for a diversified life sciences and diagnostics group. Adjusted diluted EPS of $7.66 provides a second anchor for valuation work, especially when compared with the $196.74 share price visible on 20 July 2026. The same report says core revenue fell 5.8% in 2025, a useful comparison point because it shows the operating backdrop was weaker than the headline sales line alone suggests. Investors often focus on that gap: revenue still came in at $23.9 billion, but the underlying trend moved lower. That makes margins the key variable. With a 27.3% adjusted operating margin, Danaher kept a strong earnings profile despite the 5.8% core revenue decline. The report provides the 2025 revenue, EPS, margin, and core revenue...
Keep reading with a free account
The rest of this article, and every signal for Danaher, is in your free account.
